Efficacy and Safety of Upadacitinib Treatment for Moderate to Severe Atopic Dermatitis in Real-World Practice in Japan
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The efficacy and safety of upadacitinib treatment for moderate to severe atopic dermatitis in real-world practice in Japan
J Dermatol 2022 Aug 19;[EPub Ahead of Print], T Hagino, H Saeki, N KandaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.